Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Denosumab Treatment in Bisphosphonate Unresponsive Postmenopausal Osteoporotic

NCT04702204 is registered in ClinicalTrials.gov with Nigde Omer Halisdemir University as lead sponsor.

NCT NCT04702204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04702204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Denosumab Treatment in Bisphosphonate Unresponsive Postmenopausal Osteoporotic
Lead sponsor
Nigde Omer Halisdemir University
Phase
Observational
Overall status
Completed
Start date
July 1, 2020
Completion date
August 15, 2021
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal osteoporosis